PTEN and Familial prostate cancer: While other FISH studies dealing with 12p deletions in prostate cancer are lacking, we are confident with our data, also because the selected threshold of 60% of cells required to have fewer 12p than centromere 12 signals to call a “12p deletion” has been earlier extensively validated by our group for PTEN deletions [11].